glp 1 agonist history GLP-1R Agonists for Weight Loss Historical timeline of GLP-1 biology,
Description
Stop the drug, and the signal wins
Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trial
While surgery still delivers the most extreme weight loss, the convenience and scalability of injectables may shift patient and physician preferences over time
"The right response to this research is vigilance and monitoring, not alarm," he said
2022;24(1):p
